Northern Trust
INAB icon

Northern Trust’s IN8bio INAB Stock Holding History

Northern Trust’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6K Buy
21,734
+1,294
+6% +$1.95K ﹤0.01% 4328
2026
Q1 		$30.3K Buy
20,440
+3,040
+17% +$5.88K ﹤0.01% 4303
2025
Q4 		$40.7K Buy
+17,400
New +$33.1K ﹤0.01% 4321
2025
Q2 		– Sell
-3,114
Closed -$15.5K – 4451
2025
Q1 		$15.5K Hold
3,114
– – ﹤0.01% 4362
2024
Q4 		$24K Buy
3,114
+2,114
+211% +$18.6K ﹤0.01% 4360
2024
Q3 		$8.1K Sell
1,000
-1,538
-61% -$27.9K ﹤0.01% 4390
2024
Q2 		$64.5K Buy
2,538
+904
+55% +$29K ﹤0.01% 4160
2024
Q1 		$57.8K Hold
1,634
– – ﹤0.01% 4202
2023
Q4 		$67.6K Buy
1,634
+192
+13% +$6.14K ﹤0.01% 4182
2023
Q3 		$45K Hold
1,442
– – ﹤0.01% 4193
2023
Q2 		$66.6K Buy
1,442
+1,000
+226% +$62.5K ﹤0.01% 4144
2023
Q1 		$17.2K Hold
442
– – ﹤0.01% 4473
2022
Q4 		$30.6K Buy
+442
New +$24.7K ﹤0.01% 4399

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust's INAB Position: Q2 2026 in Review

Northern Trust increased its IN8bio (INAB) stake by 6.3% in Q2 2026, buying an estimated $1.95K and bringing the position to 21,734 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4328.

Northern Trust first reported a position in INAB in Q4 2022 and has held it in 13 quarters since. The position peaked at $67.6K in Q4 2023. 21 funds tracked by Wall St. Rank hold INAB as of Q2 2026.

  • Northern Trust held 21,734 shares of IN8bio worth $30.6K as of Q2 2026.
  • Northern Trust bought 1,294 IN8bio shares in Q2 2026, an estimated $1.95K.
  • IN8bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4328 holding.
  • Northern Trust first reported a position in IN8bio in Q4 2022 and has held it in 13 quarters since.
  • Northern Trust's IN8bio position peaked at $67.6K in Q4 2023.
  • 21 funds tracked by Wall St. Rank held IN8bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.